Kangji Medical Holdings Limited (FRA:50J)

Market Cap	993.57M
Revenue (ttm)	133.47M
Net Income (ttm)	76.94M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	12.91
Forward PE	n/a
Dividend	0.03 (3.55%)
Ex-Dividend Date	May 27, 2025

Volume	1,260
Average Volume	567
Open	0.7900
Previous Close	0.8250
Day's Range	0.7900 - 0.7900
52-Week Range	0.5550 - 0.9600
Beta	n/a
RSI	40.67
Earnings Date	May 20, 2025

About Kangji Medical Holdings

Kangji Medical Holdings Limited, an investment holding company, designs, develops, manufactures, and sells minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, disposable trocars, disposable electrocoagulation forceps, ultrasonic scalpels, staplers and other disposable products. It provides reusable ultrasonic scalpels soft tissue cutting and hemostatic scalpel, and laparoscopic surgical instrument. In addition, the company offers instruments, including 4K UHD ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2004
• Employees: 1,007
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 50J

Financial Performance

In 2024, Kangji Medical Holdings's revenue was 1.01 billion, an increase of 8.92% compared to the previous year's 926.02 million. Earnings were 581.44 million, an increase of 15.36%.

Financial numbers in CNY